| Ticker | ABSI |
|---|---|
| ISIN | US00091E1091 |
| Sector | Consumo básico |
| Industria | Biotechnology |
| Mercado | NASDAQ |
| Capitalización | $773,348,825 |
| Beta | 2.01 |
| Sitio web | https://www.absci.com |
| CEO | Sean McClain |
| Fecha de IPO | 22/07/2021 |
| País | US |
| Dirección | 18105 SE Mill Plain Boulevard, Vancouver, WA, 98683 |
| Volumen | 5,572,061 |
Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process. Absci Corporation was founded in 2011 and is headquartered in Vancouver, Washington.
El precio actual de Absci Corporation (ABSI) es de 4.98, con una variación del 5.63%.
Absci Corporation opera en el sector Healthcare, industria Biotechnology.
Compara brokers con acceso a las principales bolsas internacionales, con bajas comisiones, custodia y herramientas de análisis para invertir en acciones.
Compara brokers para acciones